Edesa News and Events
News Releases
Edesa Announces $3.5M Private Placement Led by CEO and Healthcare-Focused Investors
June 11, 2026
Edesa Reports Positive Exploratory Data for Paridiprubart in Patients with Acute Kidney Injury
June 5, 2026
Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury
May 19, 2026
Edesa Biotech Reports Fiscal 2nd Quarter 2026 Results
May 14, 2026
Edesa Biotech Invited for Oral Showcase at Respiratory Innovation Summit
March 31, 2026
Edesa Biotech Advances Vitiligo Program for Planned Mid-2026 Enrollment
March 26, 2026
Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart Study
February 24, 2026
Edesa Biotech Reports Fiscal 1st Quarter 2026 Results
February 13, 2026
Edesa Biotech Reports Fiscal Year 2025 Results
December 12, 2025
Edesa Biotech Announces Upcoming Conference Schedule
October 31, 2025
Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study
October 28, 2025
Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results
August 8, 2025